ID: ALA4704513
Type: Functional
Description: Antiviral activity against Human adenovirus 5 infected in 293beta5 cells assessed as inhibition of plaque formation at 10 uM incubated for 7 days by GFP reporter gene assay relative to control
Organism: Human adenovirus 5
Cell type: HEK293
Bioactivity
Activity Types for Assay ALA4704513
Inhibition
Parent Molecular Weight | ALogP | Polar Surface Area |
---|---|---|
327.12 | 3.86 | 3.86 |
297.14 | 3.53 | 3.53 |
339.18 | 3.91 | 3.91 |
442.37 | 4.97 | 4.97 |
408.33 | 4.71 | 4.71 |
462.42 | 6.07 | 6.07 |
365.26 | 5.31 | 5.31 |
430.34 | 5.63 | 5.63 |
477.43 | 7.35 | 7.35 |
494.42 | 6.01 | 6.01 |
381.30 | 5.58 | 5.58 |
456.16 | 6.87 | 6.87 |
330.82 | 4.65 | 4.65 |
379.29 | 5.70 | 5.70 |
380.27 | 4.12 | 4.12 |
330.82 | 4.65 | 4.65 |
437.41 | 7.50 | 7.50 |
405.33 | 5.58 | 5.58 |
404.25 | 4.66 | 4.66 |
421.71 | 6.22 | 6.22 |
427.29 | 5.44 | 5.44 |
379.29 | 5.23 | 5.23 |
467.15 | 5.72 | 5.72 |
455.26 | 6.58 | 6.58 |
577.55 | 8.73 | 8.73 |
387.27 | 5.56 | 5.56 |
403.27 | 5.27 | 5.27 |
464.39 | 5.45 | 5.45 |
353.25 | 5.02 | 5.02 |
480.39 | 5.76 | 5.76 |
422.70 | 5.61 | 5.61 |
344.84 | 4.96 | 4.96 |
379.29 | 4.98 | 4.98 |
417.29 | 5.57 | 5.57 |
349.26 | 5.60 | 5.60 |
472.19 | 6.39 | 6.39 |
339.22 | 4.77 | 4.77 |
473.25 | 6.72 | 6.72 |
379.29 | 5.61 | 5.61 |
455.26 | 6.58 | 6.58 |
523.26 | 7.60 | 7.60 |
325.20 | 4.02 | 4.02 |
325.20 | 4.38 | 4.38 |
365.26 | 5.31 | 5.31 |
388.25 | 4.96 | 4.96 |
369.25 | 4.13 | 4.13 |
466.16 | 6.33 | 6.33 |
348.81 | 4.79 | 4.79 |
348.81 | 4.79 | 4.79 |
340.21 | 3.32 | 3.32 |
379.29 | 5.70 | 5.70 |
409.36 | 6.72 | 6.72 |
405.26 | 5.70 | 5.70 |
440.33 | 4.89 | 4.89 |
439.70 | 6.36 | 6.36 |
339.22 | 4.77 | 4.77 |
353.25 | 4.80 | 4.80 |
383.28 | 4.52 | 4.52 |
355.22 | 3.75 | 3.75 |
379.29 | 5.55 | 5.55 |
410.30 | 3.70 | 3.70 |
351.23 | 4.77 | 4.77 |
422.70 | 5.61 | 5.61 |
489.71 | 7.24 | 7.24 |
413.30 | 3.52 | 3.52 |
394.30 | 4.36 | 4.36 |